RA Capital Management »

Surrozen shares owned by RA Capital Management

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.1M 283k 10.95

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Biogen SH (BIIB)
Eliem Therapeutics SH (ELYM)
Rxsight SH (RXST)
Avidity Biosciences SH (RNA)
Dyne Therapeutics SH (DYN)
Geron Corp SH (GERN)
Pepgen SH (PEPG)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)

View all positions for RA Capital Management

Top funds holding Surrozen

RA Capital Management
Alyeska Investment Group
Armistice Capital
Nantahala Capital Management
Stempoint Capital
Euclidean Capital
Stonepine Capital Management
CVI Holdings
Vanguard Group
Arrowpoint Asset Management
Board of Trustees of The Leland Stanford Junior University
Morgan Stanley
Geode Capital Management
Renaissance Technologies
BlackRock

View all funds holding Surrozen